Zura Bio Ltd’s Market Journey: Closing Strong at 4.1, Up 1.49

Ulysses Smith

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The closing price of Zura Bio Ltd (NASDAQ: ZURA) was $4.1 for the day, up 1.49% from the previous closing price of $4.04. In other words, the price has increased by $1.49 from its previous closing price. On the day, 2.34 million shares were traded. ZURA stock price reached its highest trading level at $4.13 during the session, while it also had its lowest trading level at $3.5701.

Ratios:

Our analysis of ZURA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.40 and its Current Ratio is at 8.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Leerink Partners on November 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $15.

On September 05, 2024, H.C. Wainwright started tracking the stock assigning a Neutral rating and target price of $5.

On May 03, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $26.Piper Sandler initiated its Overweight rating on May 03, 2024, with a $26 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when Thiara Parvinder sold 1,001,633 shares for $2.73 per share. The transaction valued at 2,734,458 led to the insider holds 0 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZURA now has a Market Capitalization of 266574016 and an Enterprise Value of 125288040.

Stock Price History:

The Beta on a monthly basis for ZURA is 0.26, which has changed by -0.063926935 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, ZURA has reached a high of $5.07, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 103.51%, while the 200-Day Moving Average is calculated to be 155.46%.

Shares Statistics:

ZURA traded an average of 1.59M shares per day over the past three months and 7308770 shares per day over the past ten days. A total of 62.06M shares are outstanding, with a floating share count of 40.98M. Insiders hold about 36.97% of the company’s shares, while institutions hold 42.68% stake in the company. Shares short for ZURA as of 1757894400 were 458086 with a Short Ratio of 0.29, compared to 1755216000 on 544611. Therefore, it implies a Short% of Shares Outstanding of 458086 and a Short% of Float of 0.7799999999999999.

Earnings Estimates

. The current market rating for Zura Bio Ltd (ZURA) reflects the collective analysis of 7.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.13 and low estimates of -$0.21.

Analysts are recommending an EPS of between -$0.64 and -$0.78 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.78, with 7.0 analysts recommending between -$0.7 and -$0.91.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.